Transitioning to Traditional COVID-19 Coverage Post Public Health Emergency

As the public health emergency for COVID-19 ends on May 11^th, there are many questions about what to expect as COVID-19 vaccines and treatments transition from the federal Public Health Emergency (PHE) phase to the traditional healthcare marketplace, including issues around coverage, access and availability. To help address these and other questions, the COVID-19 Vaccine Education and Equity Project (CVEEP) held a webinar for its over 250 partners, bringing together medical and policy experts to breakdown the anticipated changes impacting COVID-19 vaccines and treatments in the post PHE environment.

Panelists included:

• Mario Ramirez, Managing Director of Opportunity Labs and Emergency Medicine Physician
• Tochi Iroku-Malize, President of AAFP and Family Physician
• Brent Ewig, Chief Policy and Government Relations Officer of the Association of Immunization Managers
• Sue Peschin, President and CEO of the Alliance for Aging Research (moderator)